You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antiplatelet therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Ischemic Stroke, Thrombocytopenia Trial (aspirin, clopidogrel, cilostazol, and dipyridamole)

Not yet recruiting
  • Acute Ischemic Stroke
  • Thrombocytopenia
  • aspirin, clopidogrel, cilostazol, and dipyridamole
  • (no location specified)
Sep 21, 2023

Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)

Not yet recruiting
  • Intracranial Aneurysm
  • Stent Complication
  • Ticagrelor monotherapy
  • Dual Antiplatelet Therapy
  • (no location specified)
Aug 23, 2023

Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual

Recruiting
  • Coronary Artery Disease
  • +6 more
  • De-escalated Dual Antiplatelet Therapy
  • Dual Antiplatelet Therapy
  • Beijing, China
    Fuwai Hospital
Dec 13, 2022

Patients With Symptomatic Peripheral Arterial Disease

Recruiting
  • Peripheral Arterial Disease
    • Leicester, United Kingdom
      University Hospitals Leicester
    Sep 13, 2023

    MYOCARDIAL INFARCTION Trial in Paris (single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by

    Not yet recruiting
    • MYOCARDIAL INFARCTION
    • single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.
    • Paris, IDF, France
      Hopital Pitié Salpetrière
    Jan 10, 2023

    Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)

    Not yet recruiting
    • Elevated Lipoprotein(a) Level
    • +3 more
    • 24 Months DAPT
    • 12 Months DAPT
    • Beijing, Beijing, China
      Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
    Aug 26, 2023

    Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual

    Recruiting
    • Atrial Fibrillation
    • short postimplantation dual antiplatelet therapy
    • +3 more
    • Warsaw, Mazowieckie, Poland
      National Institute of Cardiology
    Dec 14, 2022

    Intracranial Aneurysm Trial in Beijing (Adjustment of Antiplatelet Drugs)

    Not yet recruiting
    • Intracranial Aneurysm
    • Adjustment of Antiplatelet Drugs
    • Beijing, Beijing, China
      Department of Neurosurgery, Beijing Tiantan Hospital.
    Apr 21, 2023

    Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor

    Not yet recruiting
    • Dual Antiplatelet Therapy
    • +2 more
    • P2Y12 inhibitor de-escalation
    • Messina, Italy
    • +1 more
    Jun 12, 2023

    Atrial Fibrillation, Atrial Appendage, Anticoagulants Trial in Pessac, Toulouse (drug, device, other)

    Recruiting
    • Atrial Fibrillation
    • +4 more
    • Double antiplatelet therapy
    • +3 more
    • Pessac, France
    • +1 more
    Oct 13, 2022

    Acute Coronary Syndrome Trial (rivaroxaban)

    Not yet recruiting
    • Acute Coronary Syndrome
    • (no location specified)
    Feb 20, 2023

    Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic

    Recruiting
    • Aortic Stenosis
    • +4 more
    • Aspirin group
    • Non-antithrombotic group
    • Shinjuku, Tokyo, Japan
      Keio University Hospital
    Aug 17, 2023

    Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)

    Not yet recruiting
    • Coronary Heart Disease
    • Beijing, Beijing, China
      Fuwai Hospital
    Oct 15, 2023

    Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

    Not yet recruiting
    • Ischemic Stroke
    • Transient Ischemic Attack
    • Genetic testing
    • Singapore, Singapore
      Singapore General Hospital
    Mar 9, 2023

    Acute Ischemic Stroke, Atrial Fibrillation, Stenosis, Carotid Trial (Anticoagulant Oral, Anticoagulation combined with

    Not yet recruiting
    • Acute Ischemic Stroke
    • +3 more
    • Anticoagulant Oral
    • Anticoagulation combined with antiplatelet therapy
    • (no location specified)
    Sep 21, 2023

    Coronary Artery Disease Trial (Angiolite: Sirolimus-eluting stent, Xience: Sirolimus-eluting stent, 1-month DAPT)

    Not yet recruiting
    • Coronary Artery Disease
    • Angiolite: Sirolimus-eluting stent
    • +3 more
    • (no location specified)
    Jul 11, 2023

    Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided

    Not yet recruiting
    • Percutaneous Coronary Intervention
    • +2 more
    • Algorithm-guided DAPT duration
    • Standard-of-care DAPT duration
    • Bern, Switzerland
      Bern University Hospital
    Feb 16, 2023

    Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual

    Recruiting
    • Atrial Fibrillation
    • short postimplantation dual antiplatelet therapy
    • +3 more
    • Warsaw, Mazowieckie, Poland
      National Institute of Cardiology
    Jun 30, 2022

    Tracheotomy With and Without Dual Antiplatelet Therapy

    Recruiting
    • Tracheostomy Hemorrhage
    • Tracheotomy
    • Nidda, Germany
      Neurologische Klinik Bad Salzhausen
    Oct 29, 2022

    Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid

    Recruiting
    • Acute Coronary Syndrome
    • Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
    • Monotherapy: Ticagrelor alone OR Prasugrel alone
    • São Paulo, Brazil
      Hospital Israelita Albert Einstein
    Mar 2, 2023

    Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)

    Recruiting
    • Acute Coronary Syndrome
    • No aspirin
    • 1-month DAPT
    • Kyoto, Japan
      Kyoto University Graduate School of Medicine
    Nov 16, 2022

    Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease Trial in Clermont-Ferrand (monitoring the use of anticoagulant and/or

    Not yet recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • Rendu Osler Disease
    • monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease
    • Clermont-Ferrand, France
      CHU clermont-ferrand
    Nov 29, 2022

    Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)

    Recruiting
    • Acute Coronary Syndrome
    • +2 more
    • Genoss DES™ stent
    • Wonju, Gangwon State, Korea, Republic of
      Wonju Severance Christian Hospital
    Oct 4, 2023

    Coronary Artery Disease Trial in Amsterdam

    Not yet recruiting
    • Coronary Artery Disease
      • Amsterdam, Noord-Holland, Netherlands
      • +1 more
      Sep 26, 2022

      Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)

      Recruiting
      • Coronary Artery Disease
      • +2 more
      • Genoss DES™ stent
      • Wŏnju, Gangwon State, Korea, Republic of
        Wonju Severance Christian Hospital
      Oct 4, 2023